Bradford Crutchfield is CCO at 10x Genomics, Inc. (TXG). They have made 39 open-market trades across 2 companies since 2007, most recently 2022-05-23.
CIK 0001246406
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $6K since 2022, against 38 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TXG | SELL | 2022-05-23 | 2022-05-25 | $48.76 | $14K | +1.6% | +8.7% | -22.4% |
| TXG | BUY | 2022-05-13 | 2022-05-17 | $40.49 | $6K | +8.2% | -24.2% | -2.8% |
| TXG | SELL | 2022-02-22 | 2022-02-24 | $78.60 | $23K | -12.3% | -8.7% | -40.6% |
| TXG | SELL | 2022-02-15 | 2022-02-17 | $95.13 | $1.6M | -4.6% | -17.4% | -41.3% |
| TXG | SELL | 2022-01-12 | 2022-01-14 | $118.58 | $3.5M | -15.6% | -12.1% | -36.2% |
| TXG | SELL | 2021-12-13 | 2021-12-15 | $139.38 | $4.2M | +1.7% | -26.8% | -60.4% |
| TXG | SELL | 2021-11-22 | 2021-11-24 | $148.38 | $42K | -2.5% | -4.3% | -47.9% |
| TXG | SELL | 2021-11-12 | 2021-11-16 | $164.96 | $5.4M | -10.1% | -15.2% | -44.3% |
| TXG | SELL | 2021-10-12 | 2021-10-14 | $157.30 | $5.3M | +7.6% | +2.6% | -22.8% |
| TXG | SELL | 2021-09-13 | 2021-09-15 | $174.57 | $4.8M | -2.4% | -2.5% | -12.7% |
| TXG | SELL | 2021-08-23 | 2021-08-25 | $161.85 | $44K | +14.7% | -7.3% | -11.5% |
| TXG | SELL | 2021-08-12 | 2021-08-16 | $159.94 | $4.0M | +1.5% | -1.0% | +0.1% |
| TXG | SELL | 2021-07-12 | 2021-07-14 | $186.53 | $5.4M | +6.6% | -4.9% | -5.7% |
| TXG | SELL | 2021-06-14 | 2021-06-16 | $191.33 | $4.0M | +5.5% | -10.4% | -18.5% |
| TXG | SELL | 2021-05-24 | 2021-05-26 | $162.66 | $46K | +11.1% | +12.7% | +0.4% |
| TXG | SELL | 2021-05-12 | 2021-05-13 | $134.69 | $4.4M | +21.7% | +40.0% | +18.2% |
| TXG | SELL | 2021-04-12 | 2021-04-13 | $185.62 | $5.5M | -1.4% | -30.5% | -5.7% |
| TXG | SELL | 2021-03-12 | 2021-03-16 | $157.01 | $4.7M | +0.6% | +18.8% | +15.8% |
| TXG | SELL | 2021-02-01 | 2021-02-03 | $175.83 | $5.3M | +5.6% | -14.6% | +1.4% |
| TXG | SELL | 2021-01-04 | 2021-01-06 | $140.02 | $4.3M | +24.3% | +26.5% | +34.5% |
| TXG | SELL | 2020-12-01 | 2020-12-03 | $151.30 | $5.1M | +3.3% | -2.9% | +19.6% |
| TXG | SELL | 2020-11-02 | 2020-11-04 | $136.65 | $4.1M | -7.2% | +2.2% | +25.2% |
| TXG | SELL | 2020-10-01 | 2020-10-05 | $125.52 | $2.6M | +23.2% | +7.9% | +7.0% |
| TXG | SELL | 2020-09-01 | 2020-09-03 | $113.78 | $3.4M | +13.5% | +21.2% | +34.3% |
| TXG | SELL | 2020-08-03 | 2020-08-05 | $99.27 | $3.3M | +5.7% | +6.4% | +37.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.